We are live on ! Find out more
CGH

Crossmark Global Holdings Portfolio holdings

AUM $7.71B
1-Year Est. Return 37.66%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+37.66%
3 Year Est. Return
+112.26%
5 Year Est. Return
+139.33%
10 Year Est. Return
AUM
$4.25B
AUM Growth
+$237M
Cap. Flow
+$37.5M
Cap. Flow %
0.88%
Top 10 Hldgs %
14.79%
Holding
1,330
New
78
Increased
604
Reduced
560
Closed
34

Top Sells

Rank Stock Value
1
TRI icon
Thomson Reuters
TRI
+$13.3M
2
ABBV icon
AbbVie
ABBV
+$12.9M
3
SBUX icon
Starbucks
SBUX
+$11.8M
4
NMR icon
Nomura Holdings
NMR
+$11.3M
5
EMR icon
Emerson Electric
EMR
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 25.14%
2 Financials 14.2%
3 Healthcare 12.1%
4 Consumer Discretionary 11%
5 Industrials 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABB
51
DELISTED
ABB Ltd
ABB
$17.5M 0.41%
510,644
+1,534
+0.3% +$51.4K
ADBE icon
52
Adobe
ADBE
$104B
$17M 0.4%
44,182
+10,041
+29% +$3.57M
AMGN icon
53
Amgen
AMGN
$219B
$16.8M 0.39%
69,309
+1,621
+2% +$398K
NKE icon
54
Nike
NKE
$62.1B
$16.7M 0.39%
136,525
+3,923
+3% +$482K
PAYX icon
55
Paychex
PAYX
$42.7B
$16.6M 0.39%
145,299
-15,920
-10% -$1.81M
DGX icon
56
Quest Diagnostics
DGX
$26.3B
$16.6M 0.39%
117,392
-1,978
-2% -$283K
WFC icon
57
Wells Fargo
WFC
$265B
$16.4M 0.39%
439,374
+21,473
+5% +$936K
MDT icon
58
Medtronic
MDT
$110B
$16.2M 0.38%
201,367
-97,664
-33% -$7.96M
ASML icon
59
ASML
ASML
$656B
$15.8M 0.37%
23,225
-397
-2% -$255K
RTX icon
60
RTX Corp
RTX
$300B
$15.8M 0.37%
160,988
+1,271
+0.8% +$125K
BMY icon
61
Bristol-Myers Squibb
BMY
$131B
$15.7M 0.37%
226,846
+12,225
+6% +$862K
BDX icon
62
Becton Dickinson
BDX
$48.8B
$15.5M 0.37%
62,768
+47,454
+310% +$11.6M
AXP icon
63
American Express
AXP
$231B
$15.4M 0.36%
93,087
-1,976
-2% -$328K
SO icon
64
Southern Company
SO
$107B
$14.9M 0.35%
214,221
-139
-0.1% -$9.36K
CNQ icon
65
Canadian Natural Resources
CNQ
$94.9B
$14.7M 0.35%
532,564
+1,792
+0.3% +$50.8K
CNI icon
66
Canadian National Railway
CNI
$76.4B
$14.5M 0.34%
122,632
-285
-0.2% -$33.7K
ABBV icon
67
AbbVie
ABBV
$430B
$14.2M 0.33%
88,882
-84,689
-49% -$12.9M
ASX icon
68
ASE Group
ASX
$82B
$14.1M 0.33%
1,763,364
+21,677
+1% +$158K
COST icon
69
Costco
COST
$421B
$14M 0.33%
28,097
-3,485
-11% -$1.71M
PYPL icon
70
PayPal
PYPL
$51.1B
$13.9M 0.33%
182,574
+112,702
+161% +$8.68M
EA icon
71
Electronic Arts
EA
$13.7M 0.32%
113,482
+961
+0.9% +$113K
MCHP icon
72
Microchip Technology
MCHP
$40.5B
$13.6M 0.32%
161,735
+3,439
+2% +$274K
LLY icon
73
Eli Lilly
LLY
$1.06T
$13.2M 0.31%
38,493
-15,839
-29% -$5.34M
K
74
DELISTED
Kellanova
K
$13.2M 0.31%
209,688
+1,521
+0.7% +$96.1K
CDNS icon
75
Cadence Design Systems
CDNS
$93.3B
$13.1M 0.31%
62,494
-5,100
-8% -$965K

Similar funds

Crossmark Global Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, Crossmark Global Holdings held 1,330 positions worth $4.25B, up 5.9% from $4.01B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Crossmark Global Holdings's Q1 2023 filing shows 78 new, 604 increased, 560 reduced and 34 closed positions. Its largest new stake was Bunge Global: 122,662 shares worth $11.7M. The largest sale was Thomson Reuters, an estimated $13.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Crossmark Global Holdings's largest Q1 2023 buy was Bunge Global: 122,662 shares worth $11.7M.
  • Crossmark Global Holdings added most to Lowe's Companies in Q1 2023, an estimated $15M increase.
  • Crossmark Global Holdings's biggest Q1 2023 reduction was Thomson Reuters, cutting an estimated $13.3M.
  • Crossmark Global Holdings fully exited Canon, Inc. in Q1 2023, selling an estimated $2.25M.
  • Crossmark Global Holdings's ten largest holdings make up 15% of its $4.25B portfolio in Q1 2023.
  • Crossmark Global Holdings opened 78 new positions and closed 34 in Q1 2023.
  • Crossmark Global Holdings's portfolio value rose 5.9% quarter-over-quarter to $4.25B.

Based on Crossmark Global Holdings's 13F filing for Q1 2023, filed 12 May 2023.